Published on February 12th, 2021 📆 | 7923 Views ⚑0
AbCellera Appoints Ester Falconer, Ph.D., as Chief Technology Officer
AbCellera (Nasdaq: ABCL) announced today that Ester Falconer, Ph.D., has been appointed as Chief Technology Officer (CTO), effective January 28, 2021.
As CTO, Dr. Falconer will lead AbCellera’s long-term strategy in the development, aggregation, and integration of technologies that improve the speed and success of therapeutic antibody discovery
from target to investigational new drug application submission.